1. Home
  2. VTSI vs TLSA Comparison

VTSI vs TLSA Comparison

Compare VTSI & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VirTra Inc.

VTSI

VirTra Inc.

N/A

Current Price

$2.86

Market Cap

51.0M

ML Signal

N/A

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

HOLD

Current Price

$1.02

Market Cap

145.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTSI
TLSA
Founded
1993
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
51.0M
145.1M
IPO Year
1999
2017

Fundamental Metrics

Financial Performance
Metric
VTSI
TLSA
Price
$2.86
$1.02
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
★ $5.00
N/A
AVG Volume (30 Days)
18.9K
★ 569.4K
Earning Date
05-11-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $185,971.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$27.30
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.86
$0.76
52 Week High
$6.29
$2.33

Technical Indicators

Market Signals
Indicator
VTSI
TLSA
Relative Strength Index (RSI) 40.46 52.52
Support Level N/A $0.90
Resistance Level $3.59 $1.20
Average True Range (ATR) 0.08 0.08
MACD -0.00 0.02
Stochastic Oscillator 12.50 72.74

Price Performance

Historical Comparison
VTSI
TLSA

About VTSI VirTra Inc.

VirTra Inc is a U.S.-based company that is engaged in the sale and development of judgmental use-of-force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company operates in six segments, which include Simulators and Accessories, Extended Service, Customized software and Custom content, Installation and Training, Design and Prototyping, and Subscription Training Equipment Partnership. The majority of its revenue is generated from the Simulators and Accessories segment.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.

Share on Social Networks: